Biotechnology Value Fund L P - 30 Jun 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share (UNCY)

Filing Manager
Biotechnology Value Fund L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Unicycive Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
UNCY
Shares outstanding
14.2M shares
Disclosed Ownership
1.42M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
14 Aug 2025, 16:05
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.7% 777K 0 777K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.7% 777K 0 777K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.4% 592K 0 592K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.4% 592K 0 592K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 35.5K 0 35.5K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 35.5K 0 35.5K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.7% 1.37M 0 1.37M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 1.42M 0 1.42M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 1.42M 0 1.42M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 1.42M 0 1.42M /s/ Mark N. Lampert Mark N. Lampert